Alpash Patel, DPM
Foot & Ankle Surgery · Houston, TXNPI 1598731374
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,976 of the $26,070 with a category attached, or 65.1%. Aroa Biosurgery Incorporated accounts for 67.8% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $9,526 and has fallen 59.1% since, to $3,899 in 2025.
Across 152 payments — averaging $171.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aroa Biosurgery Incorporated$18K
- Smith+Nephew$3K
- Kerecis Limited$2K
- Mimedx Group, Inc.$1K
- Amgen$500
- Celularity Inc.$385
- plus $1K from 15 others
What the payments were for
- Consulting fees$16,97665%
- Travel & lodging$1,9327%
- Food & beverage$7,01527%
- Other$1471%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aroa Biosurgery Incorporated | 21 | $17,676 |
| Smith+Nephew | 63 | $3,261 |
| Kerecis Limited | 6 | $1,672 |
| Mimedx Group, Inc. | 16 | $1,412 |
| Amgen(2 entities) | 14 | $500 |
| Celularity Inc. | 1 | $385 |
| Paratek Pharmaceuticals, Inc. | 5 | $297 |
| Integra Lifesciences Corporation | 3 | $186 |
| Convatec Inc. | 9 | $177 |
| Cook Medical LLC | 2 | $161 |
| Next Science LLC | 1 | $118 |
| Hartmann USA, Inc. | 2 | $49 |
| Urgo Medical North America, LLC | 1 | $29 |
| Organogenesis Inc. | 1 | $24 |
| Inari Medical, Inc. | 1 | $24 |
| KCI USA, Inc. | 1 | $22 |
| Acera Surgical, Inc. | 1 | $18 |
| AbbVie | 1 | $17 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Coloplast | 1 | $15 |
| Medela LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PICO$1,595
- Grafix$1,534
- Kerecis Omega3 Wound$1,409
- Versajet$1,398
- COLLAGENASE SANTYL$1,398
- Kerecis Omega3 SurgiClose$864
- Kerecis Omega3 Marigen$743
- Kerecis Omega3 Surgibind$679
- Kerecis Omega3 GraftGuide$679
- UltraMist$385
- KRYSTEXXA$352
- NUZYRA$250
- ACell$147
- STRAVIX PL$135
- PICO7$124
- RENASYS GO$124
- Santyl$122
- Stravix$122
- GRAFIX PL$122
- Xperience$118
How this compares
$26,070 in reported general payments places this provider in the 85th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 13 | $287 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $192 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Houston
- Kevin VarnerHouston$1.1M
- Sherman NaglerHouston$602K
- Abdul NurudeenHouston$404K
- Orlando RiveraHouston$384K
- Brian LepowHouston$309K
- Yueh LeeHouston$95K
- William GranberryHouston$84K
- Nathaniel AlabiHouston$71K
- Jorge MatukHouston$45K
- William McGarveyKaty$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.